Mereo BioPharma Group plc (MREO) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 40.03M | 45.02M | 52.41M | 61.42M | 66.9M | 74.76M | 86.72M | 93.94M | 53.5M | 63.76M | 52.26M | 68.91M |
| Cash & Short-Term Investments | 36.22M | 40.99M | 48.7M | 56.13M | 62.48M | 69.8M | 80.52M | 87.43M | 48.66M | 57.42M | 47.07M | 53.52M |
| Cash Only | 36.22M | 40.99M | 48.7M | 56.13M | 62.48M | 69.8M | 80.52M | 87.43M | 48.66M | 57.42M | 47.07M | 53.52M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 1.5M | 0 | 3.75M | 2.4M | 3.25M | 0 | 2.67M | 0 | 0 | 0 | 10.03M |
| Days Sales Outstanding | - | - | - | 559.2 | - | - | - | - | - | - | - | 101.42 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 3.81M | 2.53M | 3.71M | 0 | 851K | 129K | 3.28M | 2.63M | 2.6M | 5.37M | 3.56M | 3.62M |
| Total Non-Current Assets | 580K | 897K | 1.2M | 1.21M | 1.42M | 1.63M | 2.02M | 2.19M | 2.44M | 2.74M | 2.25M | 33.56M |
| Property, Plant & Equipment | 199K | 381K | 552K | 740K | 869K | 984K | 1.22M | 1.32M | 1.47M | 1.65M | 1.35M | 1.99M |
| Fixed Asset Turnover | - | - | - | 0.62x | - | - | - | - | - | 0.67x | 0.32x | 4.53x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 381K | 516K | 643K | 470K | 554K | 643K | 799K | 866K | 972K | 1.09M | 892.61K | 31.57M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 0 | 0 |
| Total Assets | 40.61M | 45.92M | 53.6M | 62.63M | 68.32M | 76.39M | 88.75M | 96.13M | 55.94M | 66.5M | 54.51M | 102.47M |
| Asset Turnover | - | - | - | 0.01x | - | - | - | - | - | 0.02x | 0.01x | 0.09x |
| Asset Growth % | -40.55% | -39.89% | -39.6% | -34.85% | 22.14% | 14.87% | 62.82% | -6.19% | - | -14.1% | -29.59% | -22.08% |
| Total Current Liabilities | 6.18M | 4.3M | 6.02M | 7.56M | 7.5M | 13.85M | 14.21M | 15.47M | 11M | 9.49M | 7.78M | 22.19M |
| Accounts Payable | 3.23M | 1.33M | 879K | 1.14M | 2.92M | 2.44M | 1.98M | 2.7M | 2.46M | 2.35M | 1.92M | 2.43M |
| Days Payables Outstanding | 673.77 | - | 92.78K | 1.4K | - | 749.5 | - | - | - | -719.31 | 1.16K | 64.43 |
| Short-Term Debt | 0 | 202K | 397K | 0 | 0 | 5.54M | 5.55M | 4.93M | 4.63M | 0 | 0 | 5.32M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 2.95M | 2.77M | 4.74M | 1.64M | 988K | -413K | 358K | 6.04M | 327K | 741K | 607.37K | 7.74M |
| Current Ratio | 6.48x | 10.46x | 8.71x | 8.13x | 8.92x | 5.40x | 6.10x | 6.07x | 4.86x | 6.72x | 6.72x | 3.11x |
| Quick Ratio | 6.48x | 10.46x | 8.71x | 8.13x | 8.92x | 5.40x | 6.10x | 6.07x | 4.86x | 6.72x | 6.72x | 3.11x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 383K | 699K | 988K | 897K | 744K | 1.57M | 2M | 2.01M | 2.1M | 6.48M | 5.31M | 6.91M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.39M | 3.6M | 4.66M |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 187K | 394K | 552K | 727K | 906K | 742.61K | 1.24M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 383K | 699K | 988K | 897K | 744K | 1.39M | 1.61M | 1.46M | 1.37M | 1.18M | 963.92K | 1.01M |
| Total Liabilities | 6.56M | 5M | 7M | 8.45M | 8.24M | 15.42M | 16.21M | 17.48M | 13.1M | 15.96M | 13.08M | 29.09M |
| Total Debt | 0 | 202K | 397K | 601K | 747K | 6.43M | 6.68M | 6.16M | 6.02M | 5.95M | 4.88M | 11.83M |
| Net Debt | -36.22M | -40.79M | -48.3M | -55.52M | -61.74M | -63.37M | -73.84M | -81.27M | -42.64M | -51.47M | -42.19M | -41.68M |
| Debt / Equity | - | 0.00x | 0.01x | 0.01x | 0.01x | 0.11x | 0.09x | 0.08x | 0.14x | 0.12x | 0.12x | 0.16x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -437.57x | -318.61x | -354.60x | -608.00x | -70.59x | -19.15x | -41.50x | -36.02x | -27.87x | - | -10.75x | -0.70x |
| Total Equity | 34.05M | 40.92M | 46.6M | 54.18M | 60.08M | 60.97M | 72.54M | 78.65M | 42.84M | 50.54M | 41.42M | 73.38M |
| Equity Growth % | -43.32% | -32.89% | -35.76% | -31.12% | 40.25% | 20.64% | 75.11% | 7.18% | -16.66% | -1.68% | -19.41% | -13.37% |
| Book Value per Share | 0.21 | 0.26 | 0.29 | 0.34 | 0.38 | 0.39 | 0.47 | 0.55 | 0.31 | 0.37 | 0.30 | 0.58 |
| Total Shareholders' Equity | 34.05M | 40.92M | 46.6M | 54.18M | 60.08M | 60.97M | 72.54M | 78.65M | 42.84M | 50.54M | 41.42M | 73.38M |
| Common Stock | 3.15M | 3.13M | 3.13M | 3.13M | 3.13M | 3.06M | 3.05M | 3.03M | 2.77M | 2.77M | 2.27M | 2.45M |
| Retained Earnings | -507.54M | -501.02M | -493.67M | -486.64M | -472.03M | -462.88M | -455.84M | -440.84M | -428.58M | -419.63M | -343.95M | -434.86M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.23M | -1.01M | 0 |
| Accumulated OCI | -12.57M | -10.82M | -10.91M | -8.64M | -15.29M | -18.85M | -11.1M | -18.28M | -18.28M | -17.48M | -14.33M | 178.76M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |